PATHFINDER 2 Fact Sheet
Initial data as presented at ESMO 2025
PATHFINDER 2 (NCT05155605) is the largest interventional Multi-Cancer Early Detection (MCED) study conducted in the U.S.1The study provides further validation of the Galleri® MCED test in…
